Nikol Formulation Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 02-01-2025
- Paid Up Capital ₹ 4.00 M
as on 02-01-2025
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 02-01-2025
- Satisfied Charges ₹ 1.50 Cr
as on 02-01-2025
- Revenue 21.94%
(FY 2020)
- Profit 754.99%
(FY 2020)
- Ebitda 33.73%
(FY 2020)
- Net Worth 348.35%
(FY 2020)
- Total Assets -7.29%
(FY 2020)
About Nikol Formulation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Neerajkumar Singh and Raghuvirsinh Solanki serve as directors at the Company.
- CIN/LLPIN
U24230GJ2013PTC075960
- Company No.
075960
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Sabarkantha, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nikol Formulation Private Limited offer?
Nikol Formulation Private Limited offers a wide range of products and services, including Laxatives, Cardiovascular Drugs & Medication, Kidney Drugs, Sexual Wellness Products, Fertility Enhancer, Diabetes Medicine, Antacid Drugs, Antacid Syrup, Metformin Tablets, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Nikol Formulation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neerajkumar Singh  | Director | 16-Jul-2022 | Current |
| Raghuvirsinh Solanki | Director | 16-Jul-2022 | Current |
Financial Performance of Nikol Formulation.
Nikol Formulation Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 21.94% increase. The company also saw a substantial improvement in profitability, with a 754.99% increase in profit. The company's net worth Soared by an impressive increase of 348.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nikol Formulation?
In 2020, Nikol Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anhox Healthcare Private LimitedActive 19 years 4 monthsNeerajkumar Singh and Raghuvirsinh Solanki are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 23 Jun 2020 | ₹5.00 M | Open |
Others Creation Date: 14 Mar 2014 | ₹7.50 M | Satisfied |
Others Creation Date: 08 Mar 2014 | ₹7.50 M | Satisfied |
How Many Employees Work at Nikol Formulation?
Nikol Formulation has a workforce of 27 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nikol Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nikol Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
